- Home
- MDGL vs GHC Comparison
MDGL vs GHC Comparison
Compare MDGL & GHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDGL
- GHC
- Stock Information
- Founded
- MDGL 2011
- GHC 1877
- Country
- MDGL United States
- GHC United States
- Employees
- MDGL N/A
- GHC N/A
- Industry
- MDGL Biotechnology: Pharmaceutical Preparations
- GHC Other Consumer Services
- Sector
- MDGL Health Care
- GHC Real Estate
- Exchange
- MDGL Nasdaq
- GHC Nasdaq
- Market Cap
- MDGL 6.1B
- GHC 5.1B
- IPO Year
- MDGL N/A
- GHC N/A
- Fundamental
- Price
- MDGL $427.10
- GHC $1,008.33
- Analyst Decision
- MDGL Strong Buy
- GHC
- Analyst Count
- MDGL 10
- GHC 0
- Target Price
- MDGL $485.78
- GHC N/A
- AVG Volume (30 Days)
- MDGL 294.9K
- GHC 50.3K
- Earning Date
- MDGL 10-30-2025
- GHC 10-29-2025
- Dividend Yield
- MDGL N/A
- GHC 0.71%
- EPS Growth
- MDGL N/A
- GHC 426.70
- EPS
- MDGL N/A
- GHC 155.13
- Revenue
- MDGL $515,547,000.00
- GHC $4,834,649,000.00
- Revenue This Year
- MDGL $394.08
- GHC $0.54
- Revenue Next Year
- MDGL $61.80
- GHC $6.39
- P/E Ratio
- MDGL N/A
- GHC $6.57
- Revenue Growth
- MDGL 3421.98
- GHC 4.73
- 52 Week Low
- MDGL $200.63
- GHC $770.06
- 52 Week High
- MDGL $463.63
- GHC $1,200.00
- Technical
- Relative Strength Index (RSI)
- MDGL 50.64
- GHC 25.94
- Support Level
- MDGL $425.60
- GHC $1,140.21
- Resistance Level
- MDGL $463.63
- GHC $1,182.94
- Average True Range (ATR)
- MDGL 14.91
- GHC 29.19
- MACD
- MDGL -4.55
- GHC -21.79
- Stochastic Oscillator
- MDGL 20.84
- GHC 2.41
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
About GHC Graham Holdings Company
Graham Holdings Co. is a diversified education and media company made up of subsidiaries. Firm operations include educational services; television broadcasting; online, print, and local news; home health and hospice care; and manufacturing. The Company segments into the following seven reportable segments: Kaplan International, Higher Education, Supplemental Education, Television Broadcasting, Manufacturing, Healthcare, and Automotive. The majority of revenue comes from the Kaplan International segment, which includes higher education, test preparation, language instruction, and professional training. A large portion of company revenue also comes from the television broadcasting segment through advertising.